Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV650 (tolperisone HCl) in MS Spasticity
NCT00532532Phase 2Terminated
- Sponsor
- Avigen
- Start
- Sep 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of tolperisone in Spasticity, sponsored by Avigen. Started Sep 2007; status: terminated.
02
Drugs
tolperisone
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00532532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532532.